HDAC6 and cystic kidney disease: For instance, Tubastatin A reduced renal enlargement in SNx rats, a finding aligned with a recent report of the anti-proliferative effects of HDAC6 inhibition in kidney cells and in cystic kidney disease (Cebotaru et al., 2016).